A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer

• Glavni autori: Carlotta Defferrari (Autor), Sara Campora (Autor), Mauro D'Amico (Autor), Arnoldo Piccardo (Autor), Ennio Biscaldi (Autor), Daniela Rosselli (Autor), Ambra Pasa (Autor), Matteo Puntoni (Autor), Alberto Gozza (Autor), Alessandra Gennari (Autor), Silvia Zanardi (Autor), Rita Lionetto (Autor), Michela Bandelloni (Autor), Andrea DeCensi (Autor)
• Format: Knjiga
• Izdano: BMC, 2012-06-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>The addition of bevacizumab to standard chemotherapy prolongs progression free survival in the first line treatment of epithelial ovarian cancer (EOC), but its cost/effectiveness is debated. We assessed the safety and activity of a l...